Our Strengths

Research and development : knock down the new barriers of the knowledge, catch sight of new view for the scientific progress: in this way Ranbaxy, wants respect the trend to research that ever featured its mission. If in the Company’s DNA there’s the will of perk up the activity of research in India, Ranbaxy uses at the same time a multinational workforce that numbers over 9,000 employees. With the purpose of augmenting its strategic and operative excellence – founded upon the high quality of the Indian scientific team, internationally recognized - the Ranbaxy’s human resource department works to the construction of a truly global organization, with professional staff coming from all over the world. In the important field destined to “Research and development” (working from 1973), Ranbaxy constantly workso on the development of generics and active ingredients – wherein it enjoys an international leadership position – and also research into the creation of innovative medicines, the creation of new delivery systems, original formulations and new release technologies. An example is an innovative formulation of an antibiotics , developed by Ranbaxy and bought by a very important Pharmaceutical company: it is a modified release, that has improved the pharmacinetic and pharmadinamic profile of this leader medicine that cure urinary infections. The pre-eminence reached by Ranbaxy in the chemical-pharmaceutical research comes from the combination quality-innovation: it isn’t by accident that a large percentage of own human resources works in the research function (around 1100 personnel, of which half constitutes scientists) and the economic resources reserved to this sector reach the 7% of Company’s total sales proceeds, with a estimate of increase until the 10% in the 2007.

Active ingredients: The extreme competitive nature of the active ingredients market is interpreted by Ranbaxy such as a challenge to develop itself. This philosophy has proved to be successful demonstrated by Ranbaxy supplies, active ingredients, covering a wide area of therapeutical uses, to generic pharmaceutical companies in more than 50 countries. With established relationships in the United States and Europe, Ranbaxy is also building it’s presence in China and other Markets in the Far East and South America, representing global business in the strictest sense. The aim of this sector, that represents 12% of the Ranbaxy’s total sales, is to give extensive range of solutions in the active ingredient’s sector.